Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pterocarpans | 4 | 2016 | 21 | 0.430 |
Why?
|
| Metformin | 1 | 2013 | 65 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 807 | 0.310 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 1502 | 0.270 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 519 | 0.240 |
Why?
|
| Fundulidae | 2 | 2016 | 5 | 0.240 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2015 | 28 | 0.240 |
Why?
|
| Lysine | 1 | 2023 | 113 | 0.220 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2019 | 21 | 0.180 |
Why?
|
| Gastrectomy | 1 | 2019 | 10 | 0.170 |
Why?
|
| Feeding Behavior | 2 | 2019 | 454 | 0.160 |
Why?
|
| Sterols | 1 | 2016 | 23 | 0.140 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 213 | 0.140 |
Why?
|
| Boronic Acids | 1 | 2016 | 19 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 3 | 2016 | 111 | 0.140 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2016 | 32 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 80 | 0.140 |
Why?
|
| Propionates | 1 | 2016 | 26 | 0.140 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 40 | 0.130 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 433 | 0.130 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2016 | 48 | 0.130 |
Why?
|
| Quinolines | 1 | 2016 | 64 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2016 | 222 | 0.130 |
Why?
|
| Coumarins | 1 | 2015 | 38 | 0.130 |
Why?
|
| Proteomics | 2 | 2013 | 325 | 0.110 |
Why?
|
| Flavones | 1 | 2013 | 12 | 0.110 |
Why?
|
| Nitriles | 1 | 2013 | 69 | 0.110 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2013 | 51 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 122 | 0.110 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2013 | 52 | 0.110 |
Why?
|
| Gene Expression | 2 | 2019 | 674 | 0.110 |
Why?
|
| Triazoles | 1 | 2013 | 86 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 312 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 142 | 0.100 |
Why?
|
| Estrogens | 1 | 2013 | 202 | 0.100 |
Why?
|
| Fish Proteins | 1 | 2010 | 11 | 0.100 |
Why?
|
| Plant Extracts | 1 | 2014 | 286 | 0.090 |
Why?
|
| Obesity | 1 | 2019 | 1067 | 0.090 |
Why?
|
| Genetics, Population | 1 | 2010 | 100 | 0.090 |
Why?
|
| Estrogen Receptor beta | 1 | 2010 | 40 | 0.090 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2009 | 19 | 0.090 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 2231 | 0.090 |
Why?
|
| Structure-Activity Relationship | 3 | 2016 | 409 | 0.090 |
Why?
|
| Cell Movement | 1 | 2013 | 571 | 0.090 |
Why?
|
| Terpenes | 1 | 2009 | 28 | 0.090 |
Why?
|
| Rats, Long-Evans | 2 | 2019 | 89 | 0.090 |
Why?
|
| Anticarcinogenic Agents | 1 | 2009 | 65 | 0.080 |
Why?
|
| Catalytic Domain | 2 | 2023 | 109 | 0.080 |
Why?
|
| Animals | 9 | 2019 | 15081 | 0.080 |
Why?
|
| Stereoisomerism | 3 | 2016 | 167 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2010 | 1207 | 0.070 |
Why?
|
| Caco-2 Cells | 2 | 2016 | 52 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1015 | 0.060 |
Why?
|
| Female | 5 | 2016 | 20969 | 0.060 |
Why?
|
| Humans | 8 | 2016 | 37093 | 0.060 |
Why?
|
| Acetylation | 1 | 2023 | 98 | 0.060 |
Why?
|
| Tamoxifen | 2 | 2016 | 65 | 0.060 |
Why?
|
| Catalysis | 1 | 2023 | 179 | 0.060 |
Why?
|
| Ligands | 2 | 2015 | 349 | 0.060 |
Why?
|
| Kinetics | 2 | 2015 | 708 | 0.050 |
Why?
|
| Rats | 2 | 2019 | 3483 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 1609 | 0.050 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2001 | 9 | 0.050 |
Why?
|
| Stomach | 1 | 2001 | 45 | 0.050 |
Why?
|
| Peptide Hormones | 1 | 2019 | 20 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 626 | 0.040 |
Why?
|
| Gastrointestinal Hormones | 1 | 1999 | 2 | 0.040 |
Why?
|
| Appetite Regulation | 1 | 2019 | 9 | 0.040 |
Why?
|
| Glutamine | 1 | 1999 | 40 | 0.040 |
Why?
|
| Gastric Bypass | 1 | 2019 | 17 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2019 | 119 | 0.040 |
Why?
|
| Models, Chemical | 2 | 2015 | 207 | 0.040 |
Why?
|
| Imidazoles | 1 | 1999 | 126 | 0.040 |
Why?
|
| Hypothalamus | 1 | 2019 | 129 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 1999 | 444 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2013 | 808 | 0.040 |
Why?
|
| Weight Loss | 1 | 2019 | 131 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1198 | 0.040 |
Why?
|
| Body Weight | 1 | 2019 | 434 | 0.040 |
Why?
|
| Biological Availability | 1 | 2016 | 88 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 245 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 1908 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 224 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 67 | 0.030 |
Why?
|
| Biological Transport | 1 | 2016 | 185 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 120 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 48 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2015 | 92 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 306 | 0.030 |
Why?
|
| Base Sequence | 1 | 2016 | 997 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 435 | 0.030 |
Why?
|
| Drug Design | 1 | 2015 | 162 | 0.030 |
Why?
|
| Binding Sites | 2 | 2009 | 651 | 0.030 |
Why?
|
| Intestines | 1 | 2014 | 64 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 1568 | 0.030 |
Why?
|
| Fluorometry | 1 | 2013 | 17 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 35 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 31 | 0.030 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 30 | 0.030 |
Why?
|
| Vimentin | 1 | 2013 | 37 | 0.030 |
Why?
|
| Mesoderm | 1 | 2013 | 70 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 45 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 302 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 111 | 0.030 |
Why?
|
| Amides | 1 | 2013 | 68 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 122 | 0.030 |
Why?
|
| Pyridines | 1 | 2013 | 116 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 251 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 208 | 0.030 |
Why?
|
| Mice | 2 | 2016 | 5913 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2010 | 24 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 859 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1371 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2010 | 54 | 0.020 |
Why?
|
| Fluorescence | 1 | 2010 | 121 | 0.020 |
Why?
|
| Male | 2 | 2019 | 20025 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 56 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 212 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2010 | 110 | 0.020 |
Why?
|
| Rabbits | 2 | 2001 | 283 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 172 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 122 | 0.020 |
Why?
|
| Sesquiterpenes | 1 | 2009 | 32 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 173 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 389 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2009 | 337 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 259 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2010 | 387 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2009 | 492 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 578 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 864 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2001 | 16 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 2001 | 20 | 0.010 |
Why?
|
| Cations | 1 | 2001 | 45 | 0.010 |
Why?
|
| Potassium | 1 | 2001 | 112 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 188 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 515 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2001 | 517 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1999 | 1518 | 0.010 |
Why?
|